Pages that link to "Q40567516"
Jump to navigation
Jump to search
The following pages link to Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. The double-edged sword (Q40567516):
Displaying 50 items.
- Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach (Q24673561) (← links)
- Pharmacological basis for the therapy of pain and inflammation with nonsteroidal anti-inflammatory drugs (Q24792554) (← links)
- Renal and cardiovascular effects of non-steroidal anti-inflammatories and selective cox 2 inhibitors (Q28168380) (← links)
- Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users (Q28182449) (← links)
- Mucosa protective therapy with long-term nonsteroidal antirheumatic drugs (Q28199428) (← links)
- Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis (Q28214002) (← links)
- Drug-induced side effects affecting the gastrointestinal tract (Q28219073) (← links)
- The problem with NSAIDs: what data to believe? (Q31141829) (← links)
- Economic and gastrointestinal safety comparisons of etodolac, nabumetone, and oxaprozin from insurance claims data from patients with arthritis (Q31920378) (← links)
- The pathobiology of osteoarthritis and the rationale for the use of pentosan polysulfate for its treatment (Q33540394) (← links)
- The use of analgesics in the management of pain in rheumatic diseases (Q33542921) (← links)
- Selective cyclooxygenase-2 inhibitors (Q33651424) (← links)
- Gastrointestinal effects of nonsteroidal anti-inflammatory therapy (Q33676713) (← links)
- Prophylaxis and treatment of NSAID-induced gastroduodenal disorders (Q33678334) (← links)
- Antirheumatic agents and leukocyte recruitment. New light on the mechanism of action of oxaceprol (Q33697787) (← links)
- Ethanol extract of Angelica gigas inhibits croton oil-induced inflammation by suppressing the cyclooxygenase - prostaglandin pathway (Q33708777) (← links)
- Getting control of osteoarthritis pain. An update on treatment options (Q33758867) (← links)
- Diclofenac/misoprostol. Pharmacoeconomic implications of therapy (Q33761844) (← links)
- Cyclooxygenase-2 and carcinogenesis (Q33866664) (← links)
- Diagnosis and treatment of nonsteroidal anti-inflammatory drug-associated upper gastrointestinal toxicity (Q33883996) (← links)
- Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain (Q33914378) (← links)
- Management of rheumatic diseases in children (Q33929261) (← links)
- Rheumatology: 4. Acute monoarthritis (Q34034934) (← links)
- Nonsteroidal anti-inflammatory drugs (Q34057579) (← links)
- The athlete with early knee arthritis. (Q34089855) (← links)
- Acid peptic disease in the elderly (Q34296539) (← links)
- Lornoxicam. A review of its pharmacology and therapeutic potential in the management of painful and inflammatory conditions (Q34389026) (← links)
- Effects of pentosan polysulfate in osteoarthritis of the knee: A randomized, double-blind, placebo-controlled pilot study (Q34412582) (← links)
- Gastrointestinal toxicity associated with nonsteroidal anti-inflammatory drugs. Epidemiologic and economic issues (Q34475729) (← links)
- Single doses of parecoxib sodium intravenously are as effective as ketorolac in reducing pain after oral surgery (Q34536863) (← links)
- Pathophysiology and first-line treatment of osteoarthritis (Q34579637) (← links)
- Efficacy of glucosamine, chondroitin, and methylsulfonylmethane for spinal degenerative joint disease and degenerative disc disease: a systematic review (Q34605351) (← links)
- Incidence of clinically manifest ulcers and their complications in patients with rheumatoid arthritis (Q35550442) (← links)
- The role of rofecoxib, a cyclooxygenase-2-specific inhibitor, for the treatment of non-cancer pain: A review (Q35586339) (← links)
- Synergistic anti-inflammatory effects of Laminaria japonica fucoidan and Cistanche tubulosa extract (Q36076586) (← links)
- Potential anti-inflammatory, antioxidant and antimicrobial activities of Sambucus australis. (Q36271915) (← links)
- Enhancing Skin Permeation of Biphenylacetic Acid (BPA) Using Salt Formation with Organic and Alkali Metal Bases (Q36505078) (← links)
- Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial. (Q36820902) (← links)
- Liver injury from nonsteroidal anti-inflammatory drugs in the United States (Q37280079) (← links)
- Glucosamine and chondroitin for osteoarthritis (Q37354339) (← links)
- Efficacy and safety of rabeprazole in non-steroidal anti-inflammatory drug-induced ulcer in Japan (Q37402476) (← links)
- From peptic ulcer disease to NSAID gastropathy. An evolving nosology. (Q40466622) (← links)
- New nonsteroidal anti-inflammatory agents: nitric oxide donors and selective cyclooxygenase-2 inhibitors (Q40633167) (← links)
- Clinical guidelines for management (Q40905077) (← links)
- Nonsteroidal anti-inflammatory drugs: practical and theoretical considerations in their selection (Q40949566) (← links)
- Diclofenac/misoprostol. A review of its pharmacology and therapeutic efficacy in painful inflammatory conditions (Q40953063) (← links)
- Nonrenal toxicities of acetaminophen, aspirin, and nonsteroidal anti-inflammatory agents. (Q41008399) (← links)
- Effects of tripterygium wilfordii Hook F extracts on induction of cyclooxygenase 2 activity and prostaglandin E2 production (Q41071349) (← links)
- Cyclooxygenase 1 and 2 in rheumatic disease: implications for nonsteroidal anti-inflammatory drug therapy (Q41165164) (← links)
- NSAIDs and the gastrointestinal mucosa (Q41272815) (← links)